skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2―activating mutations
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2―activating mutations
Material Type:
Artigo 		Adicionar ao Meu Espaço

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2―activating mutations

MCCABE, Michael T ; OTT, Heidi M ; LAFRANCE, Louis V ; MELLINGER, Mark ; DUQUENNE, Celine ; XINRONG TIAN ; KRUGER, Ryan G ; MCHUGH, Charles F ; BRANDT, Martin ; MILLER, William H ; DHANAK, Dashyant ; VERMA, Sharad K ; GANJI, Gopinath ; TUMMINO, Peter J ; CREASY, Caretha L ; KORENCHUK, Susan ; THOMPSON, Christine ; VAN ALLER, Glenn S ; VAN LIU ; GRAVES, Alan P ; DELLA PIETRA, Anthony ; DIAZ, Elsie

Nature (London), 2012-12, Vol.492 (7427), p.108-112 [Periódico revisado por pares]

London: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial
Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial

Morschhauser, Franck ; Tilly, Hervé ; Chaidos, Aristeidis ; McKay, Pamela ; Phillips, Tycel ; Assouline, Sarit ; Batlevi, Connie Lee ; Campbell, Phillip ; Ribrag, Vincent ; Damaj, Gandhi Laurent ; Dickinson, Michael ; Jurczak, Wojciech ; Kazmierczak, Maciej ; Opat, Stephen ; Radford, John ; Schmitt, Anna ; Yang, Jay ; Whalen, Jennifer ; Agarwal, Shefali ; Adib, Deyaa ; Salles, Gilles

The lancet oncology, 2020-11, Vol.21 (11), p.1433-1442 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study
Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study

Goebeler, Maria-Elisabeth ; Knop, Stefan ; Viardot, Andreas ; Kufer, Peter ; Topp, Max S ; Einsele, Hermann ; Noppeney, Richard ; Hess, Georg ; Kallert, Stefan ; Mackensen, Andreas ; Rupertus, Kathrin ; Kanz, Lothar ; Libicher, Martin ; Nagorsen, Dirk ; Zugmaier, Gerhard ; Klinger, Matthias ; Wolf, Andreas ; Dorsch, Brigitte ; Quednau, Beate D ; Schmidt, Margit ; Scheele, Jürgen ; Baeuerle, Patrick A ; Leo, Eugen ; Bargou, Ralf C

Journal of clinical oncology, 2016-04, Vol.34 (10), p.1104-1111 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
4
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

Pastore, Alessandro, MD ; Jurinovic, Vindi, Dipl Math ; Kridel, Robert, MD ; Hoster, Eva, PhD ; Staiger, Annette M, MSc ; Szczepanowski, Monika, PhD ; Pott, Christiane, MD ; Kopp, Nadja, MSc ; Murakami, Mark, MD ; Horn, Heike, PhD ; Leich, Ellen, PhD ; Moccia, Alden A, MD ; Mottok, Anja, MD ; Sunkavalli, Ashwini, MSc ; Van Hummelen, Paul, PhD ; Ducar, Matthew, MSc ; Ennishi, Daisuke, PhD ; Shulha, Hennady P, PhD ; Hother, Christoffer, MD ; Connors, Joseph M, Prof ; Sehn, Laurie H, MD ; Dreyling, Martin, Prof ; Neuberg, Donna, ScD ; Möller, Peter, Prof ; Feller, Alfred C, Prof ; Hansmann, Martin L, Prof ; Stein, Harald, Prof ; Rosenwald, Andreas, Prof ; Ott, German, Prof ; Klapper, Wolfram, Prof ; Unterhalt, Michael, PhD ; Hiddemann, Wolfgang, Prof ; Gascoyne, Randy D, Prof ; Weinstock, David M, MD ; Weigert, Oliver, Dr

The lancet oncology, 2015-09, Vol.16 (9), p.1111-1122 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas
PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas
Material Type:
Artigo 		Adicionar ao Meu Espaço

PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas

Goodman, Aaron ; Patel, Sandip P ; Kurzrock, Razelle

Nature reviews. Clinical oncology, 2017-04, Vol.14 (4), p.203-220 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

Advani, Ranjana ; Flinn, Ian ; Popplewell, Leslie ; Forero, Andres ; Bartlett, Nancy L ; Ghosh, Nilanjan ; Kline, Justin ; Roschewski, Mark ; LaCasce, Ann ; Collins, Graham P ; Tran, Thu ; Lynn, Judith ; Chen, James Y ; Volkmer, Jens-Peter ; Agoram, Balaji ; Huang, Jie ; Majeti, Ravindra ; Weissman, Irving L ; Takimoto, Chris H ; Chao, Mark P ; Smith, Sonali M

The New England journal of medicine, 2018-11, Vol.379 (18), p.1711-1721 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial

Wang, M ; Fowler, N ; Wagner-Bartak, N ; Feng, L ; Romaguera, J ; Neelapu, S S ; Hagemeister, F ; Fanale, M ; Oki, Y ; Pro, B ; Shah, J ; Thomas, S ; Younes, A ; Hosing, C ; Zhang, L ; Newberry, K J ; Desai, M ; Cheng, N ; Badillo, M ; Bejarano, M ; Chen, Y ; Young, K H ; Champlin, R ; Kwak, L ; Fayad, L

Leukemia, 2013-09, Vol.27 (9), p.1902-1909 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

Marcus, Robert ; Davies, Andrew ; Ando, Kiyoshi ; Klapper, Wolfram ; Opat, Stephen ; Owen, Carolyn ; Phillips, Elizabeth ; Sangha, Randeep ; Schlag, Rudolf ; Seymour, John F ; Townsend, William ; Trněný, Marek ; Wenger, Michael ; Fingerle-Rowson, Günter ; Rufibach, Kaspar ; Moore, Tom ; Herold, Michael ; Hiddemann, Wolfgang

The New England journal of medicine, 2017-10, Vol.377 (14), p.1331-1344 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
9
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma

Leonard, John P ; Trneny, Marek ; Izutsu, Koji ; Fowler, Nathan H ; Hong, Xiaonan ; Zhu, Jun ; Zhang, Huilai ; Offner, Fritz ; Scheliga, Adriana ; Nowakowski, Grzegorz S ; Pinto, Antonio ; Re, Francesca ; Fogliatto, Laura Maria ; Scheinberg, Phillip ; Flinn, Ian W ; Moreira, Claudia ; Cabeçadas, José ; Liu, David ; Kalambakas, Stacey ; Fustier, Pierre ; Wu, Chengqing ; Gribben, John G

Journal of clinical oncology, 2019-05, Vol.37 (14), p.1188-1199 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

Morschhauser, Franck ; Fowler, Nathan H ; Feugier, Pierre ; Bouabdallah, Reda ; Tilly, Hervé ; Palomba, M. Lia ; Fruchart, Christophe ; Libby, Edward N ; Casasnovas, Rene-Olivier ; Flinn, Ian W ; Haioun, Corinne ; Maisonneuve, Hervé ; Ysebaert, Loic ; Bartlett, Nancy L ; Bouabdallah, Kamal ; Brice, Pauline ; Ribrag, Vincent ; Daguindau, Nicolas ; Le Gouill, Steven ; Pica, Gian M ; Martin Garcia-Sancho, Alejandro ; López-Guillermo, Armando ; Larouche, Jean-François ; Ando, Kiyoshi ; Gomes da Silva, Maria ; André, Marc ; Zachée, Pierre ; Sehn, Laurie H ; Tobinai, Kensei ; Cartron, Guillaume ; Liu, David ; Wang, Jianming ; Xerri, Luc ; Salles, Gilles A

The New England journal of medicine, 2018-09, Vol.379 (10), p.934-947 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1.769)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (1.869)
  2. magazinearticle  (3)
  3. Livros  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1977  (18)
  2. 1977Até1990  (22)
  3. 1991Até2001  (189)
  4. 2002Até2013  (853)
  5. Após 2013  (792)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.802)
  2. Japonês  (180)
  3. Francês  (20)
  4. Alemão  (20)
  5. Espanhol  (16)
  6. Chinês  (10)
  7. Russo  (5)
  8. Português  (2)
  9. Polonês  (1)
  10. Húngaro  (1)
  11. Dinamarquês  (1)
  12. Italiano  (1)
  13. Norueguês  (1)
  14. Croatian  (1)
  15. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.